EN | RU
EN | RU

Help Support

Back

Efficacy of bone marrow aspirate concentrate vs platelet-rich plasma to treat knee osteoarthritis

knee.osteoarthritis knee.osteoarthritis
knee.osteoarthritis knee.osteoarthritis

A study was carried out to compare efficacy and safety of intra-articular injections of bone marrow aspirate concentrate vs platelet-rich plasma in people having osteoarthritis of the knee.

See All

Key take away

Compared to platelet-rich plasma therapy, bone marrow aspirate concentrate therapy is safe and offers better pain relief to people having knee osteoarthritis.

Background

A study was carried out to compare efficacy and safety of intra-articular injections of bone marrow aspirate concentrate vs platelet-rich plasma in people having osteoarthritis of the knee.

Method

In this retrospective, non-randomized, comparative study, functionality and pain scores were estimated at baseline and at distinct time points post-injection over twelve months. The following three self-administered, clinically validated questionnaires were used: (i) Western Ontario and McMaster Universities Arthritis Index (WOMAC) for physical function, (ii) visual analogue scale (VAS) for pain intensity, and (iii) Knee injury and osteoarthritis outcome score (KOOS) for knee-associated quality of life and functionality.

For exploring effect of therapy on score evolution between groups (overall) and within groups (between baseline and each time point), a general linear model for repeated measures along with the Sidak test for pairwise comparisons was utilized.

Result

In the intra-articular autologous bone marrow aspirate concentrate group (19 patients, 26 knees), remarkable improvements in VAS, KOOS, and WOMAC scores were witnessed between baseline and 12 months. In the platelet-rich plasma group (10 patients, 13 knees), there were non-significant improvements in all the scores, as shown in Table 1:

Compared to platelet-rich plasma, the bone marrow aspirate concentrate elicited substantial improvement in outcomes by 51.71% on the WOMAC scale, 29.38% on the VAS scale, and 53.89% on the KOOS scale.

Conclusion

In people with symptomatic knee osteoarthritis, bone marrow aspirate concentrate injections are effective and safe to treat pain. It ameliorates pain and functionality to a greater extent when compared to platelet-rich plasma injections.

Source:

BMC Musculoskeletal Disorders

Article:

Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study

Authors:

Abed El-Hakim El-Kadiry et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: